Open Topic Search

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

If no search results for your keyword(s) were found, you are encouraged to review Agency omnibus solicitations for additional funding opportunities. Omnibus solicitations are structured to be broad, extensive Programmatic issuances with research areas related to the petitioning Agency and are not limited to predetermined Topics/Subtopics. If upon reviewing you have additional questions, you may consider reaching out to the respective Agency for clarification regarding acceptable proposals (https://www.sbir.gov/agency-contacts).

Displaying 1 - 10 of 74 results
  1. PAR-17-200 : Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)

    Release Date: 03-29-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2020

    Purpose The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage small business STTR grant applications to address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups. This FOA also encourages the deve ...

    STTR Department of Health and Human Services
  2. PAR-17-199 : Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)

    Release Date: 03-29-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2020

    Purpose The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage small business SBIR grant applications to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups. This FOA also encourages the develop ...

    SBIR Department of Health and Human Services
  3. PAR-17-275 : NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)

    Release Date: 05-10-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    Purpose To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies in the advancement of interventions for stroke prevention, treatment, and rehabilitation, NINDS has formed the NIH Stroke Clinical Trials Research Network ...

    SBIR Department of Health and Human Services
  4. PAR-17-300: NeuroNEXT Small Business Innovation in Clinical Trials (U44)

    Release Date: 06-05-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    Purpose: To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies, NINDS has formed the Neurology Network of Excellence in Clinical Trials (NeuroNEXT, www.NeuroNEXT.org). NeuroNEXT has a Clinical Coordinating Center (CC ...

    SBIR Department of Health and Human Services
  5. PA-17-302 : PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

    Release Date: 06-05-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    The SBIR program, as established by law, is intended to meet the following goals: stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs; increase the commercial application of Federally-supported research results; foster and encourage participation by socially and economically disadv ...

    SBIR Department of Health and Human Services
  6. PA-17-303 : PHS 2017-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

    Release Date: 06-05-2017Open Date: 08-05-2017 Due Dates: Multiple Close Date: 01-05-2018

    Recommended length: 1-5 pages. Present the purpose of the funding opportunity in paragraph form, addressing all of the items below. Please keep in mind that readers will appreciate clarity and brevity. The following headers may be useful in preparing this section: Purpose/Research objectives (describe the nature and need of the research opportunity) Specific Areas of Research Interest (include e ...

    STTR Department of Health and Human Services
  7. RFA-DA-18-007 : Nasal Delivery of CNS Therapeutics (R41/R42)

    Release Date: 04-25-2017Open Date: 07-24-2017Due Date: 08-23-2017Close Date: 08-23-2017

    Section I. Funding Opportunity Description    Less than 2% of small molecule pharmacotherapeutics effectively cross the blood brain barrier (BBB) . Larger molecules, such as peptides or antibodies, are virtually impenetrable. Direct routes of administration (e.g., epidural-, intracerebral- or intracerebral ventricular delivery) are invasive, costly and impractical for repeated dosing int ...

    STTR Department of Health and Human Services
  8. RFA-DA-18-006 : Nasal Delivery of CNS Therapeutics (R43/R44)

    Release Date: 04-25-2017Open Date: 07-24-2017Due Date: 08-23-2017Close Date: 08-23-2017

    Section I. Funding Opportunity Description  Less than 2% of small molecule pharmacotherapeutics effectively cross the blood brain barrier (BBB). Larger molecules, such as peptides or antibodies, are virtually impenetrable. Direct routes of administration (e.g., epidural-, intracerebral- or intracerebral ventricular delivery) are invasive, costly and impractical for repeated dosing into the CN ...

    SBIR Department of Health and Human Services
  9. RFA-DA-17-010 : Wearable to Track Recovery and Relapse Factors for People w/ Addiction (R43/R44)

    Release Date: 05-12-2017Open Date: 07-15-2017Due Date: 08-15-2017Close Date: 08-15-2017

    Background Currently there is no cost effective tool which enables researchers to study drug addiction relapse in real time. The standard remains to be urine analysis or self-report/surveys. Unfortunately, depending on the drug, urine analysis can only detect recent drug use in the previous 24 to 72 hours. Even in the best case scenario and based on lab assay results, the associated intervention r ...

    SBIR Department of Health and Human Services
  10. PAR-17-201 : Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

    Release Date: 03-09-2017Open Date: 07-09-2017 Due Dates: Multiple Close Date: 05-07-2020

    A. Overview Recent advances in neuroscience offer unprecedented opportunities to discover new treatments for nervous system disorders. However, before a new chemical entity can be tested in a clinical setting, it must undergo a process of chemical optimization to improve potency, selectivity, and drug-like properties, followed by pre-clinical safety testing to meet the standards set by the Food an ...

    SBIR Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government